![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/70 | |
A61K 31/575 | |||
A61K 31/661 | |||
A61K 31/7072 | |||
A61K 31/708 | |||
A61K 45/06 | |||
A61K 31/445 | |||
A61K 31/52 | |||
A61K 31/5375 | |||
A61K 31/58 | |||
A61K 31/6615 | |||
A61K 31/675 | |||
A61K 31/685 | |||
A61K 31/7008 | |||
A61K 31/7012 | |||
A61P 43/00 | |||
A61K 31/513 |
(11) | Number of the document | 2182936 |
(13) | Kind of document | T |
(96) | European patent application number | 08762509.1 |
Date of filing the European patent application | 2008-06-26 | |
(97) | Date of publication of the European application | 2010-05-12 |
(45) | Date of publication and mention of the grant of the patent | 2020-04-01 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2008/002207 |
Date | 2008-06-26 |
(87) | Number | WO 2009/001097 |
Date | 2008-12-31 |
(30) | Number | Date | Country code |
0712494 | 2007-06-27 | GB |
(72) |
PLATT, Frances, Mary, GB
LLOYD-EVANS, Emyr, GB
PORTER, Forbes, Dennison, US
|
(73) |
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD,
University Offices, Wellington Square, Oxford OX1 2JD,
GB
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, National Institutes of Health Office of Technology Transfer 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20892-7660, US |
(54) | SUBSTRATE REDUCTION THERAPY |
SUBSTRATE REDUCTION THERAPY |